These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39242113)

  • 1. Inflammatory biomarkers predicting long-term remission and active disease in juvenile idiopathic arthritis: a population-based study of the Nordic JIA cohort.
    Glerup M; Kessel C; Foell D; Berntson L; Fasth A; Myrup C; Nordal E; Rypdal V; Rygg M; Arnstad ED; Peltoniemi S; Aalto K; Schleifenbaum S; Høllsberg MN; Bilgrau AE; Herlin T;
    RMD Open; 2024 Sep; 10(3):. PubMed ID: 39242113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline.
    Ganeva M; Fuehner S; Kessel C; Klotsche J; Niewerth M; Minden K; Foell D; Hinze CH; Wittkowski H
    Pediatr Rheumatol Online J; 2021 May; 19(1):64. PubMed ID: 33933108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of synovial inflammation in juvenile idiopathic arthritis using superb microvascular imaging compared with power Doppler ultrasound.
    Sun P; Tong Y; Xu X; Gao M; Shi J
    Clin Exp Rheumatol; 2024 May; 42(5):1127-1134. PubMed ID: 37812475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study.
    Rypdal V; Arnstad ED; Aalto K; Berntson L; Ekelund M; Fasth A; Glerup M; Herlin T; Nielsen S; Peltoniemi S; Zak M; Rygg M; Rypdal M; Nordal E;
    Arthritis Res Ther; 2018 May; 20(1):91. PubMed ID: 29724248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis.
    Rezaei E; Hogan D; Trost B; Kusalik AJ; Boire G; Cabral DA; Campillo S; Chédeville G; Chetaille AL; Dancey P; Duffy C; Watanabe Duffy K; Gordon J; Guzman J; Houghton K; Huber AM; Jurencak R; Lang B; Morishita K; Oen KG; Petty RE; Ramsey SE; Scuccimarri R; Spiegel L; Stringer E; Taylor-Gjevre RM; Tse SML; Tucker LB; Turvey SE; Tupper S; Yeung RSM; Benseler S; Ellsworth J; Guillet C; Karananayake C; Muhajarine N; Roth J; Schneider R; Rosenberg AM
    Rheumatology (Oxford); 2020 Sep; 59(9):2402-2411. PubMed ID: 31919503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
    Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A
    Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort.
    Henrey A; Rypdal V; Rypdal M; Loughin T; Nordal E; Guzman J;
    Arthritis Res Ther; 2020 Jan; 22(1):10. PubMed ID: 31941530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Self-Reported Pain in Juvenile Idiopathic Arthritis as Related to Long-Term Outcomes: Results From the Nordic Juvenile Idiopathic Arthritis Cohort Study.
    Arnstad ED; Rypdal V; Peltoniemi S; Herlin T; Berntson L; Fasth A; Nielsen S; Glerup M; Ekelund M; Zak M; Aalto K; Nordal E; Romundstad PR; Rygg M;
    Arthritis Care Res (Hoboken); 2019 Jul; 71(7):961-969. PubMed ID: 30055093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis.
    Brunner HI; Schulert GS; Sproles A; Thornton S; Cornejo GV; Antón J; Cuttica R; Henrickson M; Foeldvari I; Kingsbury DJ; Askelson M; Liu J; Mukherjee S; Wong RL; Lovell DJ; Martini A; Ruperto N; Grom AA;
    Arthritis Res Ther; 2024 Jun; 26(1):125. PubMed ID: 38918871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory Biomarkers Can Differentiate Acute Lymphoblastic Leukemia with Arthropathy from Juvenile Idiopathic Arthritis Better Than Standard Blood Tests.
    Brix N; Glerup M; Foell D; Kessel C; Wittkowski H; Berntson L; Fasth A; Nielsen S; Nordal E; Rygg M; Hasle H; Herlin T;
    J Pediatr; 2023 Jul; 258():113406. PubMed ID: 37023943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort.
    Glerup M; Thiel S; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
    Pediatr Rheumatol Online J; 2019 Sep; 17(1):63. PubMed ID: 31500626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis.
    Mizuta M; Shimizu M; Inoue N; Ikawa Y; Nakagishi Y; Yasuoka R; Iwata N; Yachie A
    Rheumatology (Oxford); 2021 May; 60(5):2421-2426. PubMed ID: 33200207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1-results of the Canadian model in the Nordic cohort.
    Rypdal V; Guzman J; Henrey A; Loughin T; Glerup M; Arnstad ED; Aalto K; Rygg M; Nielsen S; Herlin T; Fasth A; Berntson L; Rypdal M; Nordal E;
    Arthritis Res Ther; 2019 Dec; 21(1):270. PubMed ID: 31806043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis.
    Selvaag AM; Aulie HA; Lilleby V; Flatø B
    Ann Rheum Dis; 2016 Jan; 75(1):190-5. PubMed ID: 25362042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.
    Alberdi-Saugstrup M; Zak M; Nielsen S; Herlin T; Nordal E; Berntson L; Fasth A; Rygg M; Klaus Müller ;
    Rheumatol Int; 2017 May; 37(5):695-703. PubMed ID: 28283733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.
    Glerup M; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Toftedal P; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
    Arthritis Care Res (Hoboken); 2020 Apr; 72(4):507-516. PubMed ID: 30762291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Serum Calprotectin in Defining Disease Outcomes in Non-Systemic Juvenile Idiopathic Arthritis: A Pilot Study.
    d'Angelo DM; Attanasi M; Di Donato G; Lapergola G; Flacco M; Chiarelli F; Altobelli E; Breda L
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory cytokines in monitoring the course of disease and effectiveness of treatment with etanercept (ETN) of children with oligo- and polyarticular juvenile idiopathic arthritis (JIA).
    Kaminiarczyk-Pyzalka D; Adamczak K; Mikos H; Klimecka I; Moczko J; Niedziela M
    Clin Lab; 2014; 60(9):1481-90. PubMed ID: 25291944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis.
    Sarma PK; Misra R; Aggarwal A
    Clin Rheumatol; 2008 Mar; 27(3):289-94. PubMed ID: 17703334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis.
    Kamiya Y; Kawada J; Kawano Y; Torii Y; Kawabe S; Iwata N; Ito Y
    Clin Rheumatol; 2015 Oct; 34(10):1705-12. PubMed ID: 25846830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.